Skip to content
2000
Volume 23, Issue 8
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Background

The widespread availability and accessibility of over-the-counter (OTC) medicines play a vital role in modern healthcare systems, enabling individuals to manage minor health concerns independently. However, certain OTC medications possess pharmacological properties that render them susceptible to misuse and abuse, including stimulants, laxatives, sedatives, and opiate-containing products. Misuse involves improper dosage, duration, or indication, while abuse entails non-therapeutic use to achieve psychoactive effects or other illicit purposes, potentially leading to dependence and addiction. This review explores the risk of developing psychotic symptoms associated with OTC drug misuse. Synthesizing existing literature, it comprehensively examines the relationship between antihistamines, cough medicines, and decongestants misuse, and the onset of psychotic symptoms.

Methods

A systematic literature review was carried out using Pubmed, Scopus and Web of Science databases through the following search strategy: (“diphenhydramine” OR “promethazine” OR “chlorpheniramine” OR “dimenhydrinate” OR “dextromethorphan” OR “pseudoephedrine” OR codeine- based cough medicines) AND (“abuse” OR “misuse” OR “craving” OR “addiction”) NOT review NOT (animal OR rat OR mouse). For data gathering purposes, the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was followed. Research methods were registered on PROSPERO (CRD42024527558).

Results

We analysed 46 relevant studies out of an initial pool of 2,677 articles. Key findings indicate that antihistamines, dextromethorphan, and other OTC drugs can induce psychotic symptoms, such as paranoia, hallucinations, and thought disorders when abused. Dextromethorphan is particularly associated with a chronic tendency towards psychosis, whereas other substances more commonly result in acute substance-induced psychosis.

Conclusion

The study underscores the necessity for increased awareness and specific interventions to address the misuse of OTC drugs and their potential to cause significant psychiatric disorders, emphasizing the broader public health implications of such misuse.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X344365250114064248
2025-02-18
2025-09-19

  • From This Site

    /content/journals/cn/10.2174/011570159X344365250114064248
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MartinottiG. De RisioL. VanniniC. SchifanoF. PettorrusoM. Di GiannantonioM. Substance-related exogenous psychosis: A postmodern syndrome.CNS Spectr.2021261849110.1017/S1092852920001479 32580808
     [Google Scholar]
  2. Substance Abuse and Mental Health Services Administration (US)Improving Cultural Competence. Drug Cultures and the Culture of RecoveryNational Library Of Medicine: Rockville Pike, Bethesda2014
     [Google Scholar]
  3. OrsoliniL. St John-SmithP. McQueenD. PapantiD. CorkeryJ. SchifanoF. Evolutionary considerations on the emerging subculture of the e-psychonauts and the novel psychoactive substances: A comeback to the shamanism?Curr. Neuropharmacol.2017155731737 27834144
     [Google Scholar]
  4. ChiappiniS. SchifanoF. What about “Pharming”? Issues regarding the misuse of prescription and over-the-counter drugs.Brain Sci.2020101073610.3390/brainsci10100736 33066476
     [Google Scholar]
  5. ChiappiniS. CeciF. MoscaA. Di CarloF. BurkauskasJ. PettorrusoM. MartinottiG. GuirguisA. CorkeryJ.M. ScherbaumN. SchifanoF. Di GiannantonioM. Knowledge and use of over-the-counter drugs in Italy: An exploratory survey-based study in the general population.Curr. Neuropharmacol.202321113314110.2174/1570159X20666220714104231 35838215
     [Google Scholar]
  6. SchifanoF. Coming off prescribed psychotropic medications: Insights from their use as recreational drugs.Psychother. Psychosom.202089527428210.1159/000507897 32615566
     [Google Scholar]
  7. SchifanoF. OrsoliniL. Duccio PapantiG. CorkeryJ.M. Novel psychoactive substances of interest for psychiatry.World Psychiatry2015141152610.1002/wps.20174 25655145
     [Google Scholar]
  8. AlgarniM. HadiM.A. YahyoucheA. MahmoodS. JalalZ. A mixed-methods systematic review of the prevalence, reasons, associated harms and risk-reduction interventions of over-the-counter (OTC) medicines misuse, abuse and dependence in adults.J. Pharm. Policy Pract.20211417610.1186/s40545‑021‑00350‑7 34517925
     [Google Scholar]
  9. SchifanoF. ChiappiniS. MiuliA. MoscaA. SantovitoM.C. CorkeryJ.M. GuirguisA. PettorrusoM. Di GiannantonioM. MartinottiG. Focus on over-the-counter drugs misuse: A systematic review on antihistamines, cough medicines, and decongestants.Front. Psychiatry20211265739710.3389/fpsyt.2021.657397 34025478
     [Google Scholar]
  10. De BerardisD. FornaroM. OrsoliniL. VentriglioA. VellanteF. Di GiannantonioM. Emotional dysregulation in adolescents: Implications for the development of severe psychiatric disorders, substance abuse, and suicidal ideation and behaviors.Brain Sci.202010959110.3390/brainsci10090591 32858969
     [Google Scholar]
  11. RicciV. De BerardisD. MainaG. Third-generation antipsychotics and lurasidone in the treatment of substance-induced psychoses: A narrative review.Healthcare (Basel)202412333910.3390/healthcare12030339 38338224
     [Google Scholar]
  12. MoherD. ShamseerL. ClarkeM. GhersiD. LiberatiA. PetticrewM. ShekelleP. StewartL.A. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.Syst. Rev.201541110.1186/2046‑4053‑4‑1 25554246
     [Google Scholar]
  13. PageM.J. McKenzieJ.E. BossuytP.M. BoutronI. HoffmannT.C. MulrowC.D. ShamseerL. TetzlaffJ.M. AklE.A. BrennanS.E. ChouR. GlanvilleJ. GrimshawJ.M. HróbjartssonA. LaluM.M. LiT. LoderE.W. Mayo-WilsonE. McDonaldS. McGuinnessL.A. StewartL.A. ThomasJ. TriccoA.C. WelchV.A. WhitingP. MoherD. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.BMJ20213727110.1136/bmj.n71 33782057
     [Google Scholar]
  14. ForresterM.B. Dextromethorphan abuse in texas, 2000-2009.J. Addict. Dis.201130324324710.1080/10550887.2011.581986 21745046
     [Google Scholar]
  15. RitterD. OuelletteL. SheetsJ.D. RileyB. JudgeB. CookA. HousemanJ. JonesJ.S. “Robo-tripping”: Dextromethorphan toxicity and abuse.Am. J. Emerg. Med.202038483984110.1016/j.ajem.2019.10.001 31812232
     [Google Scholar]
  16. TsayM.E. ProcopioG. AndersonB.D. Klein-SchwartzW. Abuse and intentional misuse of promethazine reported to US poison centers: 2002 to 2012.J. Addict. Med.20159323323710.1097/ADM.0000000000000124 25822213
     [Google Scholar]
  17. JunI. YoshikoY. MitsukuniM. Abuse of “BRON”: A Japanese OTC cough suppressant solution containing methylephedrine, codeine, caffeine and chlorpheniramine.Prog. Neuropsychopharmacol. Biol. Psychiatry199115451352110.1016/0278‑5846(91)90026‑W 1749828
     [Google Scholar]
  18. ScottJ. PacheD. KeaneG. BuckleH. O’BrienN. Prolonged anticholinergic delirium following antihistamine overdose.Australas. Psychiatry200715324224410.1080/10398560601147020 17516189
     [Google Scholar]
  19. RoweC. VerjeeZ. KorenG. Adolescent dimenhydrinate abuse: Resurgence of an old problem.J. Adolesc. Health1997211474910.1016/S1054‑139X(96)00291‑1 9215510
     [Google Scholar]
  20. DilichA. GirgisC. Robo-tripping: A case of robitussin abuse in a methadone maintenance patient.Psychosomatics201758554455010.1016/j.psym.2017.03.010 28576306
     [Google Scholar]
  21. AmaladossA. O’BrienS. Cough syrup psychosis.CJEM2011131535610.2310/8000.2011.100216 21324299
     [Google Scholar]
  22. JamisonS.C. VasudevaS.A. 60-year-old woman with agitation and psychosis following ingestion of dextromethorphan and opioid analgesics.J. Psychopharmacol.200923898999110.1177/0269881108092125 18583439
     [Google Scholar]
  23. SharmaA. DewanV. PettyF. Acute psychosis with Coricidin cold medicine.Ann. Pharmacother.20053991577157810.1345/aph.1G193 16076908
     [Google Scholar]
  24. WhiteR.F. HonerW.G. ProcyshynR.M. Vila-RodriguezF. Dimenhydrinate use disorder with chronic psychosis.J. Clin. Psychopharmacol.201535110510710.1097/JCP.0000000000000238 25392935
     [Google Scholar]
  25. CraigD.F. Psychosis with vicks formula 44-D abuse.CMAJ1992146711991200 1555147
     [Google Scholar]
  26. LoganB.K. YeakelJ.K. GoldfogelG. FrostM.P. SandstromG. WickhamD.J. Dextromethorphan abuse leading to assault, suicide, or homicide.J. Forensic Sci.20125751388139410.1111/j.1556‑4029.2012.02133.x 22537430
     [Google Scholar]
  27. RobergeR.J. HiraniK.H. RowlandP.L.III BerkeleyR. KrenzelokE.P. Dextromethorphan- and pseudoephedrine-induced agitated psychosis and ataxia: Case report.J. Emerg. Med.199917228528810.1016/S0736‑4679(98)00193‑0 10195488
     [Google Scholar]
  28. StanciuC.N. PendersT.M. Mania after misuse of dextromethorphan: A case report and brief review of “robotripping”.J. Addict. Med.20159215916010.1097/ADM.0000000000000104 25622122
     [Google Scholar]
  29. AbeysunderaH. CraigB. PullichZ. Promethazine-induced delirium with perceptual abnormalities: Are we thinking broadly when assessing patients?BMJ Case Rep.2021144e24178410.1136/bcr‑2021‑241784 33858904
     [Google Scholar]
  30. MohanS. BackusT. FurlanoE. HowlandM.A. SmithS.W. SuM.K. A case of massive diphenhydramine and naproxen overdose.J. Emerg. Med.202161325926410.1016/j.jemermed.2021.04.020 34148773
     [Google Scholar]
  31. BacharR. MajewskiJ.R. ShrackC. El-KhouryA. Acute psychosis and serotonin syndrome in the setting of “Triple-C” overdose: A case report.J. Med. Case Rep.202115154810.1186/s13256‑021‑03163‑z 34732250
     [Google Scholar]
  32. HinsbergerA. SharmaV. MazmanianD. Cognitive deterioration from long-term abuse of dextromethorphan: A case report.J. Psychiatry Neurosci.1994195375377 7803371
     [Google Scholar]
  33. IaboniR.P. AronowitzJ.S. Dextromethorphan abuse in a dually diagnosed patient.J. Nerv. Ment. Dis.1995183534134210.1097/00005053‑199505000‑00014 7745393
     [Google Scholar]
  34. MarshL.D. KeyJ.D. SprattE. Bulimia and dextromethorphan abuse.J. Subst. Abuse Treat.199714437337610.1016/S0740‑5472(97)00019‑6 9368214
     [Google Scholar]
  35. MartinakB. BolisR.A. BlackJ.R. FargasonR.E. BirurB. Dextromethorphan in cough syrup: The poor man’s psychosis.Psychopharmacol. Bull.20174745963 28936010
     [Google Scholar]
  36. WolfeT.R. CaravatiE.M. Massive dextromethorphan ingestion and abuse.Am. J. Emerg. Med.199513217417610.1016/0735‑6757(95)90088‑8 7893303
     [Google Scholar]
  37. ZiaeeV. Akbari HamedE. HoshmandA. AminiH. KebriaeizadehA. SamanK. Side effects of dextromethorphan abuse, a case series.Addict. Behav.20053081607161310.1016/j.addbeh.2005.02.005 16122622
     [Google Scholar]
  38. TennantF.S. Complications of methaqualone-diphenhydramine (Mandrax R) abuse.Addiction197368432733010.1111/j.1360‑0443.1973.tb01265.x 4528484
     [Google Scholar]
  39. DasS. PalappallilD.S. B C, M.; Chatterjee, S.S. Chlorpheniramine dependence presenting as mania.Asian J. Psychiatr.201730293010.1016/j.ajp.2017.07.007 28711681
     [Google Scholar]
  40. AlevizosB. Dependence and chronic psychosis with D-nor-pseudoephedrine.Eur. Psychiatry200318842342510.1016/j.eurpsy.2003.05.001 14680722
     [Google Scholar]
  41. RoyA.K.III HsiehC. CrapanzanoK. Dextromethorphan addiction mediated through the NMDA system.J. Addict. Med.20159649950110.1097/ADM.0000000000000152 26441400
     [Google Scholar]
  42. HapangamaA. KuruppuarachchiK.A.L.A. Dextromethorphan abuse.Ceylon Med. J.200853310911010.4038/cmj.v53i3.256 18982808
     [Google Scholar]
  43. AlamL.Y. NelsonA. BastiampillaiT. Cough syrup psychosis: Is it under-recognised?Aust. N. Z. J. Psychiatry201347121209121010.1177/0004867413495927 23803897
     [Google Scholar]
  44. AkermanS.C. HammelJ.L. BrunetteM.F. Dextromethorphan abuse and dependence in adolescents.J. Dual Diagn.201063-426627810.1080/15504263.2010.537515
     [Google Scholar]
  45. PollesA. GriffithJ.L. Dextromethorphan-induced mania.Psychosomatics1996371717410.1016/S0033‑3182(96)71601‑8 8600498
     [Google Scholar]
  46. BernsteinL.B. AlbertD. BaguerC. PopielM. Long-term dextromethorphan use and acute intoxication results in an episode of mania and autoenucleation.J. Addict. Med.2020144e133e13510.1097/ADM.0000000000000568 31567601
     [Google Scholar]
  47. WalkerJ. YathamL.N. Benylin (dextromethorphan) abuse and mania.BMJ1993306688289689610.1136/bmj.306.6882.896 8490415
     [Google Scholar]
  48. ButwickaA. ZalepaA. FendlerW. SzadkowskaA. MlynarskiW. Maternal depressive symptoms predict acute hospitalization among children with type 1 diabetes.Pediatr. Diabetes201314428829410.1111/pedi.12010 23350622
     [Google Scholar]
  49. GhoshA.K. PehL.H. Dextromethorphan: Abusing the overused.Singapore Med. J.2011522134135 21373741
     [Google Scholar]
  50. MillerS. Dextromethorphan psychosis, dependence and physical withdrawal.Addict. Biol.200510432532710.1080/13556210500352410 16318953
     [Google Scholar]
  51. ModiD. BhalavatR. PattersonJ.C.II Suicidal and homicidal behaviors related to dextromethorphan abuse in a middle-aged woman.J. Addict. Med.20137214314410.1097/ADM.0b013e318281a547 23388679
     [Google Scholar]
  52. PhillipsM.A. AcquistoN.M. GorodetskyR.M. WiegandT.J. Use of a physostigmine continuous infusion for the treatment of severe and recurrent antimuscarinic toxicity in a mixed drug overdose.J. Med. Toxicol.201410220520910.1007/s13181‑013‑0330‑y 24798647
     [Google Scholar]
  53. SaranJ.S. BarbanoR.L. SchultR. WiegandT.J. SelioutskiO. Chronic diphenhydramine abuse and withdrawal.Neurol. Clin. Pract.20177543944110.1212/CPJ.0000000000000304 29620065
     [Google Scholar]
  54. MurrieB. LappinJ. LargeM. SaraG. Transition of substance-induced, brief, and atypical psychoses to schizophrenia: A systematic review and meta-analysis.Schizophr. Bull.202046350551610.1093/schbul/sbz102 31618428
     [Google Scholar]
  55. PapantiD. SchifanoF. BotteonG. BertossiF. MannixJ. VidoniD. ImpagnatielloM. Pascolo-FabriciE. BonavigoT. “Spiceophrenia”: A systematic overview of “Spice”-related psychopathological issues and a case report.Hum. Psychopharmacol.201328437938910.1002/hup.2312 23881886
     [Google Scholar]
  56. ChiangM. LombardiD. DuJ. MakrumU. SitthichaiR. HarringtonA. ShukairN. ZhaoM. FanX. Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options.Hum. Psychopharmacol.2019345e271010.1002/hup.2710 31441135
     [Google Scholar]
  57. VoceA. CalabriaB. BurnsR. CastleD. McKetinR. A systematic review of the symptom profile and course of methamphetamine-associated psychosis.Subst. Use Misuse201954454955910.1080/10826084.2018.1521430 30693832
     [Google Scholar]
  58. SatelS.L.E.W. Cocaine-induced paranoia and psychosis proneness.Am. J. Psychiatry19911481217081711 1957934
     [Google Scholar]
  59. ShahD. ChandP. BandawarM. BenegalV. MurthyP. Cannabis induced psychosis and subsequent psychiatric disorders.Asian J. Psychiatr.20173018018410.1016/j.ajp.2017.10.003 29096386
     [Google Scholar]
  60. FiorentiniA. CantùF. CrisantiC. CeredaG. OldaniL. BrambillaP. Substance-induced psychoses: An updated literature review.Front. Psychiatry20211269486310.3389/fpsyt.2021.694863 35002789
     [Google Scholar]
  61. HjorthøjC. ArnfredB. BehrendtS. MøllerS.B. NordentoftM. Substance-induced psychosis as a risk factor for unipolar depression or anxiety disorders-A nationwide register-based prospective cohort study.J. Affect. Disord.202129596096610.1016/j.jad.2021.09.004 34706469
     [Google Scholar]
  62. ChiappiniS. GuirguisA. CorkeryJ.M. SchifanoF. Misuse of prescription and over-the-counter drugs to obtain illicit highs: How pharmacists can prevent abuse.Pharm. J.2020
     [Google Scholar]
  63. European Monitoring Centre for Drugs and Drug Addiction. Nonmedical use of medicines:Health and social responses.2021Available From: https://www.euda.europa.eu/publications/mini-guides/non-medical-use-of-medicines-health-and-social-responses_en
    [Google Scholar]
  64. CavallottoC. ChiappiniS. MoscaA. d’AndreaG. Di CarloF. PiroT. SusiniO. StefanelliG. Di CesareA. RicciV. PepeM. DattoliL. Di NicolaM. PettorrusoM. MartinottiG. Examining lurasidone efficacy in patients with schizophrenia spectrum illness and concurrent alcohol and substance use disorder: A prospective, multicentric, real-world investigation.J. Clin. Med.2024138220610.3390/jcm13082206 38673478
     [Google Scholar]
  65. ChiappiniS. CavallottoC. MoscaA. Di CarloF. PiroT. GiovannettiG. PasinoA. VicinelliM. LorenziniC. Di PaoloM. PepeM. Di NicolaM. RicciV. PettorrusoM. MartinottiG. Investigating the effectiveness of brexpiprazole in subjects with schizophrenia spectrum illness and co-occurring substance use disorder: A prospective, multicentric, real-world study.Pharmaceuticals (Basel)202417453510.3390/ph17040535 38675495
     [Google Scholar]
  66. ChiappiniS. MoscaA. MiuliA. Di CarloF. d’AndreaG. NapolitanoA. SantangeloM. EspositoC. RosazzaA. HaefeleE. Di PettaG. PettorrusoM. SensiS.L. MartinottiG. Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: An observational, real-world study.Adv. Dual Diagn.202316318519810.1108/ADD‑12‑2022‑0032
     [Google Scholar]
/content/journals/cn/10.2174/011570159X344365250114064248
Loading
Over-the-counter Psychosis: A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis
Curr. Neuropharmacol. 23, 956 (2025); https://doi.org/10.2174/011570159X344365250114064248
/content/journals/cn/10.2174/011570159X344365250114064248
/content/journals/cn/10.2174/011570159X344365250114064248
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): addiction; Drug abuse; drug diversion; drug misuse; OTC; over-the-counter drug misuse; pharming; psychosis; schizophrenia; substance-induced-psychosis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test